| Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease L Miele, V Valenza, G La Torre, M Montalto, G Cammarota, R Ricci, ... Hepatology 49 (6), 1877-1887, 2009 | 1582 | 2009 |
| Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ... Digestive and Liver Disease 47 (12), 997-1006, 2015 | 490 | 2015 |
| The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota ML Balmer, E Slack, A De Gottardi, MAE Lawson, S Hapfelmeier, L Miele, ... Science translational medicine 6 (237), 237ra66-237ra66, 2014 | 420 | 2014 |
| Field‐practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ... Hepatology 54 (6), 2055-2063, 2011 | 410 | 2011 |
| Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia M Venditti, M Falcone, S Corrao, G Licata, P Serra Annals of internal medicine 150 (1), 19, 2009 | 353 | 2009 |
| Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging … A Grieco, M Pompili, G Caminiti, L Miele, M Covino, B Alfei, GL Rapaccini, ... Gut 54 (3), 411-418, 2005 | 332 | 2005 |
| Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial C Loguercio, P Andreone, C Brisc, MC Brisc, E Bugianesi, M Chiaramonte, ... Free Radical Biology and Medicine 52 (9), 1658-1665, 2012 | 279 | 2012 |
| Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis L Miele, S Vallone, C Cefalo, G La Torre, C Di Stasi, FM Vecchio, ... Journal of hepatology 51 (4), 778-786, 2009 | 277 | 2009 |
| MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ... Scientific reports 7 (1), 4492, 2017 | 223 | 2017 |
| The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease L Miele, G Beale, G Patman, V Nobili, J Leathart, A Grieco, M Abate, ... Gastroenterology 135 (1), 282-291. e1, 2008 | 211 | 2008 |
| Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity V Giorgio, L Miele, L Principessa, F Ferretti, MP Villa, V Negro, A Grieco, ... Digestive and Liver Disease 46 (6), 556-560, 2014 | 176 | 2014 |
| Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test L Miele, A Grieco, A Armuzzi, M Candelli, A Forgione, A Gasbarrini, ... Official journal of the American College of Gastroenterology| ACG 98 (10 …, 2003 | 161 | 2003 |
| Impact of gut microbiota on obesity, diabetes, and cardiovascular disease risk L Miele, V Giorgio, MA Alberelli, E De Candia, A Gasbarrini, A Grieco Current cardiology reports 17, 1-7, 2015 | 157 | 2015 |
| High efficacy of 1‐week doxycycline‐and amoxicillin‐based quadruple regimen in a culture‐guided, third‐line treatment approach for Helicobacter pylori infection G Cammarota, A Martino, G Pirozzi, R Cianci, G Branca, EC Nista, ... Alimentary pharmacology & therapeutics 19 (7), 789-795, 2004 | 155 | 2004 |
| Breath testing for human liver function assessment A Armuzzi, M Candelli, MA Zocco, A Andreoli, A De Lorenzo, EC Nista, ... Alimentary pharmacology & therapeutics 16 (12), 1977-1996, 2002 | 154 | 2002 |
| Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity AL Fracanzani, L Valenti, E Bugianesi, E Vanni, A Grieco, L Miele, ... Journal of hepatology 54 (6), 1244-1249, 2011 | 142 | 2011 |
| Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease S Petta, L Miele, E Bugianesi, C Camma, C Rosso, S Boccia, D Cabibi, ... PLoS One 9 (2), e87523, 2014 | 140 | 2014 |
| Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target L Miele, G Marrone, C Lauritano, C Cefalo, A Gasbarrini, C Day, A Grieco Current Pharmaceutical Design 19 (29), 5314-5324, 2013 | 136 | 2013 |
| Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib M Iavarone, G Cabibbo, M Biolato, C Della Corte, M Maida, M Barbara, ... Hepatology 62 (3), 784-791, 2015 | 125 | 2015 |
| Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review M Pompili, M Biolato, L Miele, A Grieco World journal of gastroenterology: WJG 19 (44), 7867, 2013 | 124 | 2013 |
